Hawkins (HWKN)
(Delayed Data from NSDQ)
$106.23 USD
-0.17 (-0.16%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $106.02 -0.21 (-0.20%) 4:34 PM ET
1-Strong Buy of 5 1
D Value A Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$106.23 USD
-0.17 (-0.16%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $106.02 -0.21 (-0.20%) 4:34 PM ET
1-Strong Buy of 5 1
D Value A Growth A Momentum B VGM
Zacks News
Are These Basic Materials Stocks Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Specialty Chemical Stocks to Buy Despite Supply-Chain Snarls
by Anindya Barman
Although the specialty chemical industry is grappling with higher costs related to supply-chain and logistics disruptions, higher demand across key markets augurs well for the industry in 2022. ASIX, HWKN, ICL and LTHM are worth betting on.
Surging Earnings Estimates Signal Upside for Hawkins (HWKN) Stock
by Zacks Equity Research
Hawkins (HWKN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
New Strong Sell Stocks for November 2nd
by Zacks Equity Research
TAST, DRQ, THRM, GEF, and HWKN have been added to the Zacks Rank #5 (Strong Sell) List on November 2, 2021
Hawkins (HWKN) Q2 Earnings Lag Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of -15.19% and 3.95%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) to Report Q2 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Hawkins (HWKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Top Specialty Chemical Stocks to Buy on Demand Strength
by Anindya Barman
An upswing in demand across key end-markets such as construction and automotive instills optimism in the specialty chemical space. ASIX, HWKN, ICL and SXT are worth betting on right now.
Element Solutions (ESI) Up 27% YTD: What's Driving the Stock?
by Zacks Equity Research
Element Solutions (ESI) is benefiting from strategic acquisitions, cost discipline, and strong demand in the high-end electronics business.
Ashland (ASH) Announces $450 Million Share Buyback Program
by Zacks Equity Research
Ashland (ASH) enters into an agreement with JP Morgan Chase to repurchase a total of $450 million of its common stock.
Element Solutions (ESI) Wraps Up Acquisition of Coventya
by Zacks Equity Research
Element (ESI) completes the acquisition of Coventya. The buyout is expected to add considerable synergies and new growth opportunities.
PPG Industries (PPG) to Display EV Battery Coatings in Michigan
by Zacks Equity Research
PPG Industries (PPG) will showcase its EV battery solutions portfolio at The Battery Show and Electric Vehicle & Hybrid Technology Expo.
Hawkins (HWKN) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Hawkins (HWKN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Ashland (ASH) Arm to Divest Performance Adhesives Unit to Arkema
by Zacks Equity Research
Ashland's (ASH) sale of its performance adhesives business to Arkema will enable it to be a dedicated additive and ingredients company, and a leader in life sciences, personal care and coatings.
US Specialty Chemical Volume Growth Speeds Up in July: 4 Picks
by Anindya Barman
U.S. specialty chemical volumes went up 1.1% in July as the industry continues its recovery. ASIX, HWKN, MTX and AGFS are worth betting on right now.
Zacks Industry Outlook Highlights: Element Solutions, Minerals Technologies, AdvanSix and Hawkins
by Zacks Equity Research
Zacks Industry Outlook Highlights: Element Solutions, Minerals Technologies, AdvanSix and Hawkins
4 Stocks to Watch From the Rebounding Chemical Specialty Industry
by Anindya Barman
The Zacks Chemicals Specialty industry is poised benefit from a rebound in global industrial and manufacturing activities. ESI, MTX, ASIX and HWKN are set to gain from demand recovery and strategic actions.
Why Hawkins (HWKN) Might be Well Poised for a Surge
by Zacks Equity Research
Hawkins (HWKN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Hawkins (HWKN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 12.86% and 1.38%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Hawkins (HWKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hawkins (HWKN) Q4 Earnings and Sales Surpass Estimates
by Zacks Equity Research
Higher consumer demand for health and immunity products drove sales in Hawkins' (HWKN) Health and Nutrition segment in Q4.
Hawkins (HWKN) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 65.38% and 8.36%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Hawkins (HWKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Specialty Chemicals Stocks to Gain From Industry Turnaround
by Kaustav Ghosh
The global specialty chemicals industry seems poised to rebound on the gradual resumption of economic activities worldwide, making it prudent to invest in names like Kraton (KRA) and Hawkins (HWKN)
Hawkins (HWKN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Hawkins (HWKN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Hawkins (HWKN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 20.97% and 5.15%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?